Risperidone versus olanzapine for treatment of patients with schizophrenia
Not Applicable
- Conditions
- schizophrenia.
- Registration Number
- IRCT201709285147N3
- Lead Sponsor
- Vice chanseller of Yasuj University of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
The patients with schizophrenia are based on history, MSE, physical exam and DSMIV criteria. PANSS done at the first day of study. Before the starts of study the patients do not have to receive any drug, no pregnant and full cooperation until end of study. The patients exclude if have no any of above condition, or the existence of any side effect.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Interview- MSE-PANSS-CGI-SAS. Timepoint: Start day of study-1 month after start- 2 months after start. Method of measurement: Interview based on DSMIV- MSE-PANSS-CGI-SAS.
- Secondary Outcome Measures
Name Time Method Interview-PANSS-CGI-SAS. Timepoint: start day-1 mont dayh after start day-2 month after start. Method of measurement: interview based on DSMIV-PANSS-CGI-SAS.